Hilltop Holdings Discloses $4.8M AbbVie, $1.7M 3M Stakes in 13F

TL;DR

**Hilltop Holdings' 13F shows a diversified portfolio with notable stakes in pharma and industrials.**

AI Summary

Hilltop Holdings Inc. (NYSE: HTH) filed its 13F-HR on February 12, 2024, revealing its equity holdings as of December 31, 2023. The filing shows a diverse portfolio, including significant positions in companies like AbbVie Inc. with 31,119 shares valued at approximately $4.8 million, and 3M Co. with 15,473 shares valued at about $1.7 million. This matters to investors because it provides transparency into Hilltop's investment strategy and the types of assets it holds, which can influence its overall financial performance and stability.

Why It Matters

This filing offers a look into Hilltop Holdings' investment strategy, showing which stocks they are holding and in what quantities, which can signal their market outlook and potential future performance.

Risk Assessment

Risk Level: medium — The diversified nature of the holdings mitigates some risk, but market fluctuations in these specific holdings could still impact Hilltop's overall financial health.

Analyst Insight

Investors should review Hilltop Holdings' future 13F filings to track changes in their portfolio, especially in their larger holdings like AbbVie and 3M, to understand shifts in their investment strategy and market outlook.

Key Numbers

• 20231231 — Conformed Period of Report (The date for which the reported holdings are accurate.)
• 31,119 — Total shares of AbbVie Inc. (Represents a significant investment in the pharmaceutical sector.)
• 15,473 — Total shares of 3M Co. (Represents a notable investment in the industrial sector.)
• 0001265131 — Central Index Key (CIK) (Unique identifier for Hilltop Holdings Inc. with the SEC.)
• 20240212 — Filed As Of Date (The date the 13F-HR filing was submitted to the SEC.)

Key Players & Entities

• Hilltop Holdings Inc. (company) — the filer of the 13F-HR
• Corey G. Prestidge (person) — Executive Vice President, General Counsel and Secretary of Hilltop Holdings Inc.
• AbbVie Inc. (company) — a significant holding in Hilltop's portfolio
• 3M Co. (company) — a significant holding in Hilltop's portfolio
• $4.8 million (dollar_amount) — approximate value of AbbVie Inc. shares held by Hilltop Holdings Inc.
• $1.7 million (dollar_amount) — approximate value of 3M Co. shares held by Hilltop Holdings Inc.

Forward-Looking Statements

• Hilltop Holdings will continue to maintain a diversified portfolio with a focus on established companies. (Hilltop Holdings Inc.) — high confidence, target: 2024-09-30
• The value of their AbbVie Inc. holdings will fluctuate with pharmaceutical market trends. (AbbVie Inc.) — medium confidence, target: 2024-06-30

FAQ

Filing Documents

• primary_doc.html (13F-HR)
• primary_doc.xml (13F-HR) — 3KB
• infotable.html (INFORMATION TABLE)
• infotable.xml (INFORMATION TABLE) — 453KB
• 0001104659-24-013492.txt ( ) — 457KB

From the Filing

SEC FORM 13F-HR The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 12-31-2023 Check here if Amendment    Amendment Number: This Amendment (Check only one.):    is a restatement.    adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Hilltop Holdings Inc. Address: 6565 Hillcrest Ave. Dallas , TX   75205 Form 13F File Number: 028-15359 CRD Number (if applicable): The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Corey G. Prestidge Title: Executive Vice President, General Counsel and Secretary Phone: 214-855-2177 Signature, Place, and Date of Signing: /s/ Corey G. Prestidge Dallas ,  TX 02-09-2024 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)    13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)    13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 934 Form 13F Information Table Value Total: 882,109,627 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] No. Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK 1 PlainsCapital Corp 028-15365 2 PlainsCapital Bank 028-15369 3 Hilltop Securities Holdings LLC 028-18782 4 HILLTOP SECURITIES INC. 028-18780 000006220 801-55529

View Full Filing

View this 13F-HR filing on SEC EDGAR